Announcement of bioresources developed by the CRISPR/Cas9 technology

Broad Institute has permitted RIKEN BRC to collect, preserve and distribute the genome edited bioresources using the CRISPR/Cas9 technology

■ Broad Institute has generously permitted RIKEN BioResource Research Center (RIKEN BRC) to collect, preserve and distribute the genome edited bioresources using the CRISPR/Cas9 technology. The CRISPR/Cas9 genome edited bioresources include mouse strains, experimental plants (Arabidopsis thaliana and Brachypodium distachyon), human and mouse cell line, microbes and DNA materials. RIKEN BRC is now able to receive, maintain and replicate the CRISPR/Cas9 genome edited bioresources, and distribute them to not-for-profit academic research by concluding the specific Material Transfer Agreement with an article set by Broad Institute which prohibits distribution to for-profit research purposes. RIKEN BRC is looking forward to receiving many deposits and requests from the scientific community.

■ When you have developed the CRISPR/Cas9 genome edited bioresources, please consider depositing them in RIKEN BRC. Such deposits will contribute significantly to the promotion of science. In addition, deposition will free you from burden for time-consuming preparation and distribution of bioresources to fellow researchers. We will make our best efforts to carefully preserve and maintain the deposited bioresources so that we can meet the needs of researchers around the world.

If you have any questions regarding the permission by Broad Institute, please contact Kusayama at Center Director Office, RIKEN BRC (tsukuba-mta@ml.riken.jp) .

For questions regarding specific resources and the distribution procedure, please contact the appropriate division: